EDGAR Filing Documents for 0001279569-07-001022

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001279569-07-001022

Filing Date

2007-07-13

Accepted

2007-07-13 09:18:38

Documents

Period of Report

2007-07-12

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	lorus6k.htm	6-K	15955
2	MATERIAL CHANGE REPORT	ex991.htm	EX-99.1	31068
3	BY-LAW	ex992.htm	EX-99.2	106783
4	ARTICLE OF INCORPORATION	ex993.htm	EX-99.3	4090
5	PAGE 1	art_p1.jpg	GRAPHIC	83007
6	PAGE 2	art_p2.jpg	GRAPHIC	138674
7	PAGE 3	art_p3.jpg	GRAPHIC	122304
8	PAGE 4	art_p4.jpg	GRAPHIC	65615
9	PAGE 5	art_p5.jpg	GRAPHIC	25893
10	PAGE 6	art_p6.jpg	GRAPHIC	42343
	Complete submission text file	0001279569-07-001022.txt		818685

Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7

Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7

LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 07977602
SIC: 2836 Biological Products, (No Diagnostic Substances)